FALSE HOPE ON BREAST CANCER?

A CLAIM THAT THE CAUSE HAS BEEN FOUND IS BEING LABELED PREMATURE

Craig Malbon and his colleagues were convinced that they had made a momentous discovery. So they held a press conference at New York City's Grand Hyatt Hotel to announce it. What they had found, Malbon told reporters last week, was an enzyme that acts as the master switch for breast cancer, a disease that kills 44,000 women in the U.S. each year. "This gives us a new diagnostic tool and a new therapeutic strategy," maintained Malbon, a pharmacologist at the State University of New York at Stony Brook.

Or does it? What the SUNY team found was that some breast-cancer cells...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!